A Crack In Creation: A Nobel Prize Winner's Insight into the Future of Genetic Engineering

by Jennifer A. Doudna

doing so are simply too invasive and too risky. To treat these diseases, we’ll need to deliver CRISPR into the patient’s body, to the tissue where the disease is exerting its greatest effect.